University of Texas Southwestern Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Texas Southwestern Medical Center sits in the top decile of US sponsors by registered trial count (#39 of 15,742 sponsors by registered trial count).
University of Texas Southwestern Medical Center: 837 sponsored US clinical trials, 162 recruiting.
University of Texas Southwestern Medical Center sponsors 837 registered US clinical trials on ClinicalTrials.gov, 162 of them currently recruiting, and 503 completed. 126 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 9 trials.
Top-decile sponsor footprint
University of Texas Southwestern Medical Center ranks in the top decile of sponsors by registered trial count (#39 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
503 of 608 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
837 total, page 5 of 17
Developing Strategies for Implementation and Use of the Operating Room Black Box (ORBB)
NCT06917183
Erlotinib for Hepatocellular Carcinoma Chemoprevention
NCT04172779
Value of Potassium Magnesium Citrate in Preventing and Treating Hypertension in African Americans
NCT05145309
Adaptive Dosing of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma
NCT07689175
Cholinergic Enhancement of Theta
NCT07228338
Pregnenolone for Cannabis Use Disorder and Depression
NCT07685964
PET/CT Imaging in Carriers of TTR Mutations
NCT07591038
An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder
NCT07693608
Early Discharge With Subcutaneous Furosemide Versus Standard Care in Acute Heart Failure
NCT07018297
Response With Interim PSMA PET in Metastatic Castration-sensitive Prostate Cancer for Optimization of Adaptive Metastasis-directed Radiotherapy Delivery
NCT07674771
Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer
NCT06552000
Reducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchicine in CKD
NCT07654231
Comparing Alkalinizing Agents Efficacy on Stone Risk in Patients on a Metabolically Controlled Diet
NCT04651088
Parent-Adolescent Relationships, Emotional Regulation, and HRV in Adolescents With Depression
NCT07430774
Noninvasive CA Monitoring Validation and Autonomic Modulation in Aneurysmal Subarachnoid Hemorrhage
NCT07577739
TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies
NCT07692217
Prospective Observational Multimodal Neuromonitoring in Adult NSICU Patients
NCT07577713
Neuronavigated aiTBS for TRD
NCT07329153
Pediatric Epilepsy
NCT07350551
Prospective Observational Multimodal Neuromonitoring During High-Risk Adult Surgery
NCT07577726
THIO and Cadonilimab in Resectable Hepatocellular Carcinoma
NCT07446257
Ventilation Performance and Feedback Simulation Trial
NCT07352709
A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Patients
NCT07573332
HIV/HBV/HCV Triple Screening in Primary Care
NCT07031219
Combination Versus Alone Liposomal Bupivacaine Blocks in Minimally Invasive Thoracic Surgery-1
NCT07254650
LET for Fibromyalgia
NCT07201818
Oncology Acute Care Follow-up Intervention Study
NCT07550192
Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease
NCT07280702
Avatar Contraception Communication Training
NCT05995574
Curriculum for Airway Skills in Critically Ill Adults: a Delphi Evaluation
NCT06689748
Remote Methadone Ingestion Surveillance Trial (RMIST)
NCT05259501
Digital Remote Home Monitoring for Heart Failure
NCT05988749
The Effects of Mannose Supplementation on Glycosylation and Protein Levels in Human Sera
NCT06507735
Evaluating Intercostobrachial Nerve Block's Effect on Pain Control After Shoulder Replacement
NCT06042608
Effects of Antihypertensive Drug Treatment on Brain Blood Flow, Cognition, and Regulation of Nervous System in Older Adults With Hypertension.
NCT06287580
A Novel Approach for Reducing Hyperoxaluria and Kidney Stone Risk.
NCT06481150
Medically Tailored Groceries and Food Resource Coaching
NCT06242808
Socioecological Factors Associated With Ethnic Disparities in Bariatric Surgery Utilization and Post-WLS
NCT06342050
Food Supplementation Delivered Conditionally vs Not Among Patients With Heart Failure
NCT06115369
Muscle Relaxation for Pediatric Adenotonsillectomy
NCT06225466
Walk Together: A Family-Based Intervention for Hypertension In African Americans
NCT05671302
Pressure Alternating Shoes
NCT06026813
Identifying Strategies to Curtail Weight Regain After GLP-1 Receptor Agonist Treatment Cessation
NCT06273163
Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV
NCT04820933
CHARGE Study: CHoice ARchitecture Genetic tEsting
NCT06284330
Multidisciplinary Study to Verify Blood Pressure Documentation and Response to Titration of Intravenous Medications
NCT06253780
Screening for and Responding to Food Insecurity Among Infusion Patients
NCT05889780
Combining Broad Based Light (BBL), Fractionated 1927 (MOXI) and Dual Wavelength 2940/1470 (HALO)
NCT06091215
Heat Waves and the Elderly With COPD
NCT06295523
Vasopressor Outcomes in Spine Surgery
NCT06053398
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 106 |
| Phase 2 | 122 |
| Phase 3 | 28 |
| Phase 4 | 98 |
Therapeutic Areas
What is open in the University of Texas Southwestern Medical Center pipeline
162 recruiting of 837 indexed (19% open); 503 completed (60%).
Phase mix: 126 late (III/IV) vs 228 early (I/II) (early-phase heavy).
Top condition: Hypertension (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Texas Southwestern Medical Center: open-pipeline peers nationwide
Peers matched on 837 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Texas Southwestern Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 837 trials (± recruiting share)
- University of Utah · 818 trials · 17% recruiting
- University of Chicago · 796 trials · 20% recruiting
- Indiana University · 890 trials · 18% recruiting
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
Sponsors near 19% open enrollment (± trial volume)
- California Polytechnic State University-San Luis Obispo · 19% recruiting · 26 trials
- Phoenix Children's Hospital · 19% recruiting · 26 trials
- Ann & Robert H Lurie Children's Hospital of Chicago · 19% recruiting · 159 trials
- Vanderbilt University Medical Center · 19% recruiting · 677 trials
Related
What to do with this University of Texas Southwestern Medical Center page
837 registered trials is a research-attention snapshot, not an endorsement of University of Texas Southwestern Medical Center or any single study.
- 162 of University of Texas Southwestern Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertension is the condition University of Texas Southwestern Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Texas Southwestern Medical Center pipeline card: 837 registered trials from official public datasets.Report a data error.